DE60325744D1 - Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben - Google Patents
Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselbenInfo
- Publication number
- DE60325744D1 DE60325744D1 DE60325744T DE60325744T DE60325744D1 DE 60325744 D1 DE60325744 D1 DE 60325744D1 DE 60325744 T DE60325744 T DE 60325744T DE 60325744 T DE60325744 T DE 60325744T DE 60325744 D1 DE60325744 D1 DE 60325744D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- nasopharyngal
- carcinom
- preparation
- drug combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41410302P | 2002-09-27 | 2002-09-27 | |
PCT/IB2003/004922 WO2004028541A2 (en) | 2002-09-27 | 2003-09-29 | Composition for the treatment of nasopharyngeal carcinoma and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60325744D1 true DE60325744D1 (de) | 2009-02-26 |
Family
ID=32043348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60325744T Expired - Lifetime DE60325744D1 (de) | 2002-09-27 | 2003-09-29 | Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben |
Country Status (8)
Country | Link |
---|---|
US (2) | US20060166907A1 (de) |
EP (1) | EP1542691B1 (de) |
JP (1) | JP2006500421A (de) |
AT (1) | ATE419852T1 (de) |
AU (1) | AU2003274565A1 (de) |
DE (1) | DE60325744D1 (de) |
ES (1) | ES2316811T3 (de) |
WO (1) | WO2004028541A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60325744D1 (de) * | 2002-09-27 | 2009-02-26 | Sod Conseils Rech Applic | Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben |
WO2005089515A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
JP2009507032A (ja) | 2005-09-02 | 2009-02-19 | アボット・ラボラトリーズ | 新規なイミダゾ系複素環 |
WO2009151683A2 (en) | 2008-03-12 | 2009-12-17 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
JP2012508768A (ja) | 2008-11-13 | 2012-04-12 | リンク・メディスン・コーポレーション | アザキノリノン誘導体及びその使用 |
JO3156B1 (ar) | 2009-07-09 | 2017-09-20 | Novartis Ag | ايميدازولات مدمجة والتركيبات التي تشملها لعلاج الأمراض الطفيلية على مثال الملاريا |
CA3059327A1 (en) | 2017-04-24 | 2018-11-01 | Novartis Ag | Therapeutic regimen of 2-amino-l-(2-(4-fluorophenyl)-3-(4-fluorophenylamino)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8h)-yl)ethanone and combinations thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6673927B2 (en) * | 1996-02-16 | 2004-01-06 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Farnesyl transferase inhibitors |
DE69941307D1 (de) * | 1998-12-31 | 2009-10-01 | Ipsen Pharma | Prenyl transferasinhibitoren |
AU2001244167A1 (en) * | 2000-02-29 | 2001-09-12 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |
DE60325744D1 (de) * | 2002-09-27 | 2009-02-26 | Sod Conseils Rech Applic | Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben |
-
2003
- 2003-09-29 DE DE60325744T patent/DE60325744D1/de not_active Expired - Lifetime
- 2003-09-29 WO PCT/IB2003/004922 patent/WO2004028541A2/en active Application Filing
- 2003-09-29 EP EP03758540A patent/EP1542691B1/de not_active Expired - Lifetime
- 2003-09-29 JP JP2004539385A patent/JP2006500421A/ja active Pending
- 2003-09-29 ES ES03758540T patent/ES2316811T3/es not_active Expired - Lifetime
- 2003-09-29 US US10/529,431 patent/US20060166907A1/en not_active Abandoned
- 2003-09-29 AT AT03758540T patent/ATE419852T1/de not_active IP Right Cessation
- 2003-09-29 AU AU2003274565A patent/AU2003274565A1/en not_active Abandoned
-
2008
- 2008-03-06 US US12/074,729 patent/US20080161253A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20060166907A1 (en) | 2006-07-27 |
AU2003274565A1 (en) | 2004-04-19 |
AU2003274565A8 (en) | 2004-04-19 |
ES2316811T3 (es) | 2009-04-16 |
WO2004028541A2 (en) | 2004-04-08 |
WO2004028541A3 (en) | 2004-07-01 |
EP1542691A2 (de) | 2005-06-22 |
US20080161253A1 (en) | 2008-07-03 |
ATE419852T1 (de) | 2009-01-15 |
EP1542691B1 (de) | 2009-01-07 |
JP2006500421A (ja) | 2006-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20034056D0 (no) | Proliferative sykdommer | |
ATE409189T1 (de) | Farnesyl transferase-hemmende 6- heterocyclylmethyl-chinolin und chinazol-derivate | |
MXPA03010134A (es) | Derivados de ciclohexan-1-4-diamina sustituidos. | |
PT1347971E (pt) | Inibidores tiazolilicos de tirosina-cinases da familia tec | |
BG108181A (en) | Novel spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
NO20052058D0 (no) | Behandling av influensa. | |
MXPA05010711A (es) | Compuestos y composiciones novedosos como inhibidores de proteina-quinasa. | |
SE0102315D0 (sv) | Compounds | |
SE0203752D0 (sv) | New compounds | |
DE60118544D1 (de) | Methoden und zusammensetzungen zur modulation der aktivität der alpha-adrenergen rezeptoren | |
DK1255537T3 (da) | Farnesylproteintransferasehæmmere til behandling af brystcancer | |
DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
NO20014303D0 (no) | JAK-3-inhibitorer for behandling av allergiske lidelser | |
ATE275145T1 (de) | Chinazolinderivate zur behandlung von tumoren | |
UY27972A1 (es) | Derivados de hidantoína | |
DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
DE60323765D1 (de) | Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten | |
ATE323490T1 (de) | Farnesyl-protein-transferasehemmer zur behandlung der entzündlichen darmerkrankung | |
DE60127537D1 (de) | VERWENDUNG VON 2-(4-ETHOXY-PHENYL)-3-(4-METHANESULFONYL-PHENYL)-PYRAZOLOÄ1,5-bÜPYRIDAZINE ZUR BEHANDLUNG VON NICHTULZERATIVER DYSPEPSIE | |
ATE273699T1 (de) | Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie | |
NO20025405D0 (no) | Modulatorer for TNF-alfa-signalisering | |
DE60325744D1 (de) | Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben | |
TR200402230T4 (tr) | O-ikameli 6-metil-tramadol-türevleri | |
ATE273276T1 (de) | Cyclobutendion-derivate zur behandlung von artherosclerose | |
ATE282604T1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2- abhängiger krankheiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |